PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

American Made, Cheaper Abroad: Lumigan Eyedrops

Lumigan 3 ml packaging

A weekly series identifying prescription drugs manufactured in America and their prices.

Lumigan (bimatoprost) ophthalmic solution is used for the treatment symptoms from glaucoma or ocular hypertension. Lumigan, a product of the drug company Allergan, is manufactured in the U.S., but the price at U.S. pharmacies is about six times higher than in other countries. You can save around 80% by ordering it from a verified international online pharmacy: one 2.5 ml vial of Lumigan costs $114 at a Rite-Aid in New York City, but a 3 ml vial is only $22 from a PharmacyChecker.com-approved pharmacy.

Share
Tagged with: , ,

American Made, Cheaper Abroad: Invega

A weekly series identifying prescription drugs manufactured in America and their prices.

French Invega Packaging

Invega (paliperidone) tablets, a product of Jansen Pharmaceuticals, are used to treat schizophrenia and schizoaffective disorder in adults and adolescents. Invega is manufactured in the U.S., but is cheaper when ordered in other countries, even for Americans. The price at a New York City CVS for a 90-day supply of Invega 6 mg is $1,932, and that’s even taking into account the savings from a coupon. By ordering from a safe international online pharmacy, the price is only $580. Over one year a consumer could save $5,408 or 70%!

Share
Tagged with: , , ,

American Made, Cheaper Abroad: Pataday

Pataday in its American packaging

A weekly series identifying prescription drugs manufactured in America and their prices.

Pataday (olopatadine hydrochloride ophthalmic solution) is a solution used for the treatment of itchy or watering eyes caused by allergies. Pataday is manufactured in the U.S., but that doesn’t mean that’s where it’s cheapest for Americans. In fact, you can save 79% by ordering it from a verified foreign online pharmacy: one 2.5 ml vial of Pataday costs $161 at a Walgreens in New York City, but only $34 from a PharmacyChecker.com-approved pharmacy.

Share
Tagged with: , ,

American Made, Cheaper Abroad: Janumet

Janumet, manufactured in the USA weekly series identifying prescription drugs manufactured in America and their prices.

Janumet (Sitagliptin Metformin HCL) is a popular prescription drug that combines two different diabetes medications, Januvia (sitagliptin) and metformin. Janumet is only for individuals with type II diabetes. It is manufactured by Patheon in the U.S., and is marketed by Merck. Despite being made in the U.S., the price for Janumet is much lower for Americans who choose to order it from a verified international online pharmacy rather than a U.S. pharmacy. From the former, 180 pills of Janumet 50/500 mg costs $172. From the latter, the same quantity costs a staggering $1,050. That’s a 83% savings, or $3,512 over the course of one year.

Find a verified international online pharmacy today.

Share
Tagged with: , , , ,

American Made, Cheaper Abroad: Strattera

 

Strattera, manufactured in the U.S.A weekly series identifying prescription drugs manufactured in America and their prices.

 Strattera (Atomoxetine HCl) is a popular attention deficit hyperactivity disorder medication for use by children and adults. Strattera, an Eli Lilly product, is manufactured right here in the U.S.A., but is far more expensive in American pharmacies than elsewhere. In fact, the price difference is shocking – 90 capsules (25 mg) will run you $828 at a Rite-Aid in New York City; from a verified international pharmacy it only costs $310.50. That’s a 63% savings, or just under $2,100 over the course of a year.

 Check back next week for the savings on another American drug available abroad.

                                           

Share
Tagged with: , , ,

The Prices We Pay for Delay

Brand name drug manufacturers made an estimated $98 billion in sales over the past eight years by paying generic manufacturers to postpone selling low-cost generic drugs, according to a new report released by the U.S. Public Interest Research Group (PIRG). These “pay for delay” deals were recently the focus of a U.S. Supreme Court decision in which the Court ruled that companies engaging in them could be prosecuted under anti-trust laws.

PIRG’s analysis found that pay for delay agreements postponed market entry of generic drugs for an average of five years. It also found that the prices for delayed generics were on average ten times less than their brand-name counterparts.

Americans are too often victims to these higher brand name drug prices, especially those who pay for their drugs out of pocket. For example, the antidepressant Effexor XR costs $194 for a 30 day supply. Venlafaxine, the generic equivalent, costs only $17. Annually, that’s $2,124 cheaper. The venlafaxine pay for delay deal could have cost a consumer $9,983 over its 4.7 year duration.

The extra costs add up quickly. The FTC found in 2010 that these deals add $3.5 billion annually in increased healthcare costs for consumers and taxpayers, not to mention the negative health outcomes of some people skipping medication because of high costs.

We hope the Supreme Court decision will encourage the FTC to challenge and put an end to anticompetitive tactics by drug companies. In the meantime, as Americans wait for domestic action, they can find much lower cost brand medication in Canada and other international pharmacies by comparing prices on PharmacyChecker.com.

Share
Tagged with: , , ,